...
首页> 外文期刊>Women’s midlife health. >Anti-Müllerian hormone and its relationships with subclinical cardiovascular disease and renal disease in a longitudinal cohort study of women with type 1 diabetes
【24h】

Anti-Müllerian hormone and its relationships with subclinical cardiovascular disease and renal disease in a longitudinal cohort study of women with type 1 diabetes

机译:1型糖尿病女性纵向队列研究中的抗苗勒管激素及其与亚临床心血管疾病和肾脏疾病的关系

获取原文
           

摘要

BackgroundReproductive age may be a risk factor for vascular disease. Anti-Müllerian hormone (AMH) is produced by viable ovarian follicles and reflects reproductive age. We examined whether AMH concentrations were associated with markers of subclinical cardiovascular disease (CVD) and kidney disease among women with type 1 diabetes. MethodsWe performed a cross-sectional analysis of the Epidemiology of Diabetes Interventions and Complications Study . Participants included women with type 1 diabetes and ≥1 AMH measurement ( n =?390). In multivariable regression models which adjusted for repeated measures, we examined the associations between AMH with CVD risk factors, estimated glomerular filtration rate, and?albumin excretion ratio. We also examined whether initial AMH concentrations were associated with the presence of any coronary artery calcification (CAC) or carotid intima media thickness (cIMT). ResultsAfter adjustment for age, AMH was not associated with waist circumference, blood pressure, lipid profiles, or renal function. Higher initial AMH concentrations had borderline but non-significant associations with the presence of CAC after adjustment for age (odds ratio [OR] 1.08, 95% confidence interval [CI] 1.00, 1.16) which were minimally altered by addition of other CVD risk factors, although women in the 3rd quartile of AMH had lower odds of CAC than women in the lowest quartile (OR 0.40, 95% CI 0.17, 0.94). After adjustment for age, higher AMH was associated with statistically significant but only slightly higher cIMT (0.005?mm, p =?0.0087) which was minimally altered by addition of other CVD risk factors. ConclusionsAmong midlife women with type 1 diabetes, AMH has slight but significant associations with subclinical measures of atherosclerosis. Future studies should examine whether these associations are clinically significant. Trial registration NCT00360815 and NCT00360893 Study Start Date April 1994.
机译:背景生殖年龄可能是血管疾病的危险因素。抗苗勒管激素(AMH)由存活的卵泡产生,反映了生殖年龄。我们检查了1型糖尿病女性中AMH浓度是否与亚临床心血管疾病(CVD)和肾脏疾病标志物相关。方法我们对糖尿病干预和并发症流行病学进行了横断面分析。参与者包括1型糖尿病和AMH测量值≥1的女性(n =?390)。在调整了重复测量的多变量回归模型中,我们检查了AMH与CVD危险因素,估计的肾小球滤过率和白蛋白排泄率之间的关系。我们还检查了初始AMH浓度是否与任何冠状动脉钙化(CAC)或颈动脉内膜中层厚度(cIMT)相关。结果调整年龄后,AMH与腰围,血压,血脂谱或肾功能无关。校正年龄后,较高的初始AMH浓度与CAC的存在存在临界关联,但无显着关联(优势比[OR] 1.08,95%置信区间[CI] 1.00,1.16),这些最低限度是通过添加其他CVD危险因素来改变,尽管AMH第三四分位数的女性CAC几率比最低四分位数的女性低(OR 0.40,95%CI 0.17,0.94)。调整年龄后,较高的AMH与统计学上显着相关,但cIMT稍高(0.005?mm,p =?0.0087),而通过添加其他CVD危险因素的影响很小。结论在1型糖尿病中年女性中,AMH与动脉粥样硬化的亚临床指标有轻微但重要的关联。未来的研究应检查这些关联是否具有临床意义。试用注册NCT00360815和NCT00360893研究开始日期为1994年4月。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号